Joo-Seop Chung - Concepedia

Author

Joo-Seop Chung

Also Known As

Bong-Seog Kim, Chu-Myong Seong, Ho-Jin Shin, J Chung, J S Chung, J. Chung, J. S. CHUNG, J. S. Chung, J.-S. Chung, J.S. Chung

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Pusan National University Hospital Chonnam National University Hwasun Hospital Inje University Busan Paik Hospital Pusan National University Kyungpook National University Hospital

About

Joo-Seop Chung is an author at Pusan National University Hospital specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	490
2	Health Sciences	3	3	54
3	Public Health	1	1	127
4	Epidemiology	1	1	127
5	Geriatrics	1	1	17

Joo-Seop Chung

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim, Blood	2015	181
Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement Joo-Seop Chung, Ho‐Jin Shin, Sang‐Min Lee, Annals of Hematology	2011	139
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry Jong Wook Lee, Jun Ho Jang, Jin Seok Kim, International Journal of Hematology ThrombosisHemodialysisVenous ThrombosisCardiovascular DiseaseKorean Registry	2013	127
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study S. J. Kim, Jae Wook Lee, Chang Wook Jung, Haematologica	2010	106
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients Sook Jin Seong, Minkyung Lim, Sang Kyun Sohn, Annals of Oncology	2012	79
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors S.-H. Kim, Hari Menon, Saengsuree Jootar, Haematologica Hematological MalignancyChronic Myeloid LeukemiaOncologyMajor Cytogenetic ResponseMedicine	2014	67
Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy Joo-Seop Chung, Y.-M. Seol, S.-G. Kim, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderHematology	2009	64
Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients So Yeon Oh, Sang Won Shin, Su-Jin Koh, Supportive Care in Cancer	2017	36
Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy Joo-Seop Chung, Sung‐Yong Oh, Gyeong‐Won Lee, Annals of Hematology Lymphoid NeoplasiaSurgical OncologyMedicineSurgical PathologyPathology	2010	31
Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy Joo-Seop Chung, Dong‐Yeop Shin, Sung-Nam Lim, Annals of Hematology Hematological MalignancyLymphoid NeoplasiaOncologyImmunologyHematology	2016	29

Page 1